Cargando…

Human brain effects of DMT assessed via EEG-fMRI

Psychedelics have attracted medical interest, but their effects on human brain function are incompletely understood. In a comprehensive, within-subjects, placebo-controlled design, we acquired multimodal neuroimaging [i.e., EEG-fMRI (electroencephalography-functional MRI)] data to assess the effects...

Descripción completa

Detalles Bibliográficos
Autores principales:	Timmermann, Christopher, Roseman, Leor, Haridas, Sharad, Rosas, Fernando E., Luan, Lisa, Kettner, Hannes, Martell, Jonny, Erritzoe, David, Tagliazucchi, Enzo, Pallavicini, Carla, Girn, Manesh, Alamia, Andrea, Leech, Robert, Nutt, David J., Carhart-Harris, Robin L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2023
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10068756/ https://www.ncbi.nlm.nih.gov/pubmed/36940333 http://dx.doi.org/10.1073/pnas.2218949120

Ejemplares similares

DMT Models the Near-Death Experience
por: Timmermann, Christopher, et al.
Publicado: (2018)

DMT alters cortical travelling waves
por: Alamia, Andrea, et al.
Publicado: (2020)

Neural correlates of the DMT experience assessed with multivariate EEG
por: Timmermann, Christopher, et al.
Publicado: (2019)

Correction: DMT alters cortical travelling waves
por: Alamia, Andrea, et al.
Publicado: (2020)

Psychedelic-induced mystical experiences: An interdisciplinary discussion and critique
por: Mosurinjohn, Sharday, et al.
Publicado: (2023)

Effects of psilocybin versus escitalopram on rumination and thought suppression in depression
por: Barba, Tommaso, et al.
Publicado: (2022)

Time-resolved network control analysis links reduced control energy under DMT with the serotonin 2a receptor, signal diversity, and subjective experience
por: Singleton, S. Parker, et al.
Publicado: (2023)

Psychedelics alter metaphysical beliefs
por: Timmermann, Christopher, et al.
Publicado: (2021)

The effects of psilocybin and MDMA on between-network resting state functional connectivity in healthy volunteers
por: Roseman, Leor, et al.
Publicado: (2014)

Body mass index (BMI) does not predict responses to psilocybin
por: Spriggs, Meg J, et al.
Publicado: (2022)

Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience
por: Lawrence, David Wyndham, et al.
Publicado: (2022)

Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression
por: Roseman, Leor, et al.
Publicado: (2018)

Baseline Power of Theta Oscillations Predicts Mystical-Type Experiences Induced by DMT in a Natural Setting
por: Tagliazucchi, Enzo, et al.
Publicado: (2021)

Psychedelic experience dose-dependently modulated by cannabis: results of a prospective online survey
por: Kuc, Joanna, et al.
Publicado: (2021)

The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world
por: Watts, Rosalind, et al.
Publicado: (2022)

Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression
por: Murphy, Roberta, et al.
Publicado: (2022)

Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms
por: Carhart-Harris, Robin L, et al.
Publicado: (2017)

Psychedelic Communitas: Intersubjective Experience During Psychedelic Group Sessions Predicts Enduring Changes in Psychological Wellbeing and Social Connectedness
por: Kettner, H., et al.
Publicado: (2021)

Validation of the Psychological Insight Scale: A new scale to assess psychological insight following a psychedelic experience
por: Peill, Joseph M, et al.
Publicado: (2022)

Positive expectations predict improved mental-health outcomes linked to psychedelic microdosing
por: Kaertner, L. S., et al.
Publicado: (2021)

Predicting Responses to Psychedelics: A Prospective Study
por: Haijen, Eline C. H. M., et al.
Publicado: (2018)

Changes in music-evoked emotion and ventral striatal functional connectivity after psilocybin therapy for depression
por: Shukuroglou, Melissa, et al.
Publicado: (2022)

Correction to: The hidden therapist: evidence for a central role of music in psychedelic therapy
por: Kaelen, Mendel, et al.
Publicado: (2018)

The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs
por: Carhart-Harris, Robin L., et al.
Publicado: (2014)

The difference between ‘placebo group’ and ‘placebo control’: a case study in psychedelic microdosing
por: Szigeti, Balázs, et al.
Publicado: (2023)

Psychedelics and health behaviour change
por: Teixeira, Pedro J, et al.
Publicado: (2021)

Can pragmatic research, real-world data and digital technologies aid the development of psychedelic medicine?
por: Carhart-Harris, Robin L, et al.
Publicado: (2021)

Neural network models for DMT-induced visual hallucinations
por: Schartner, Michael M, et al.
Publicado: (2020)

Psychedelic therapy in the treatment of addiction: the past, present and future
por: Zafar, Rayyan, et al.
Publicado: (2023)

Effects of psilocybin therapy on personality structure
por: Erritzoe, D., et al.
Publicado: (2018)

Antidepressant effects of a psychedelic experience in a large prospective naturalistic sample
por: Nygart, Victoria Amalie, et al.
Publicado: (2022)

Self-blinding citizen science to explore psychedelic microdosing
por: Szigeti, Balázs, et al.
Publicado: (2021)

A critical evaluation of QIDS-SR-16 using data from a trial of psilocybin therapy versus escitalopram treatment for depression
por: Weiss, Brandon, et al.
Publicado: (2023)

The hidden therapist: evidence for a central role of music in psychedelic therapy
por: Kaelen, Mendel, et al.
Publicado: (2018)

Sustained, Multifaceted Improvements in Mental Well-Being Following Psychedelic Experiences in a Prospective Opportunity Sample
por: Mans, Keri, et al.
Publicado: (2021)

Relational Processes in Ayahuasca Groups of Palestinians and Israelis
por: Roseman, Leor, et al.
Publicado: (2021)

fMRI spectral signatures of sleep
por: Song, Chen, et al.
Publicado: (2022)

Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT
por: Barker, Steven A.
Publicado: (2022)

Ndfip2 is a potential regulator of the iron transporter DMT1 in the liver
por: Foot, Natalie J., et al.
Publicado: (2016)

Self-Medication for Chronic Pain Using Classic Psychedelics: A Qualitative Investigation to Inform Future Research
por: Bornemann, Julia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_efm8drh72tqh6jcpnjm5qc3bb9